329 Redirecting NK cell cytotoxicity by innate cell engagers: a differentiated and innovative approach compared to CAR-NK cells

• Ivica Fucek,
• Joachim Koch,
• Thomas Grunwald,
• Jens Pahl,
• Christian Breunig,
• Sonya Ioana Ciulean,
• Julia Uhlig,
• Thea Eichenberg,
• Joe Fischer,
• Michael Albers,
• Jan Schmollinger,
• Christoph Bach,
• Paul Franz,
• Anna Dünkel,
• Stephan Fricke,
• Ulrike Köhl

Affiliations

Ivica Fucek

2Affimed GmbH, Heidelberg, Baden-Wurttemberg, Germany

Joachim Koch

4Affimed GmbH, Heidelberg, Germany

Thomas Grunwald

3Department of Molecular and Medical Virology, Ruhr-University Bochum, Bochum, Germany

Jens Pahl

Affimed GmH, Heidelberg, Germany

Christian Breunig

2Affimed GmbH, Heidelberg, Germany

Sonya Ioana Ciulean

1Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Sachsen, Germany

Julia Uhlig

1Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Sachsen, Germany

Thea Eichenberg

1Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Sachsen, Germany

Joe Fischer

1Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Sachsen, Germany

Michael Albers

2Affimed GmbH, Heidelberg, Baden-Wurttemberg, Germany

Jan Schmollinger

2Affimed GmbH, Heidelberg, Baden-Wurttemberg, Germany

Christoph Bach

1Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Sachsen, Germany

Paul Franz

1Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Sachsen, Germany

Anna Dünkel

1Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Sachsen, Germany

Stephan Fricke

1Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Sachsen, Germany

Ulrike Köhl

1Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Sachsen, Germany